OBJECTIVE: The purpose of this cross-sectional study was to determine the prevalence and potential significance of stroke symptoms among end-stage renal disease (ESRD) patients without a prior diagnosis of stroke or TIA. METHODS: We enrolled 148 participants with ESRD from 5 clinics. Stroke symptoms and functional status, basic and instrumental activities of daily living (ADL, IADL), were ascertained by validated questionnaires. Cognitive function was assessed with a neurocognitive battery. Cognitive impairment was defined as a score 2 SDs below norms for age and education in 2 domains. IADL impairment was defined as needing assistance in at least 1 of 7 IADLs. RESULTS: Among the 126 participants without a prior stroke or TIA, 46 (36.5%) had experienced one or more stroke symptoms. After adjustment for age, sex, race, education, language, diabetes, and cardiovascular disease, participants with stroke symptoms had lower scores on tests of attention, psychomotor speed, and executive function, and more pronounced dependence in IADLs and ADLs (p ≤ 0.01 for all). After adjustment for age, sex, race, education, language, diabetes, and cardiovascular disease, participants with stroke symptoms had a higher likelihood of cognitive impairment (odds ratio [OR] 2.47, 95% confidence interval [CI] 1.03-5.92) and IADL impairment (OR 3.86, 95% CI 1.60-9.28). CONCLUSIONS: Stroke symptoms are common among patients with ESRD and strongly associated with impairments in cognition and functional status. These findings suggest that clinically significant stroke events may go undiagnosed in this high-risk population.
OBJECTIVE: The purpose of this cross-sectional study was to determine the prevalence and potential significance of stroke symptoms among end-stage renal disease (ESRD) patients without a prior diagnosis of stroke or TIA. METHODS: We enrolled 148 participants with ESRD from 5 clinics. Stroke symptoms and functional status, basic and instrumental activities of daily living (ADL, IADL), were ascertained by validated questionnaires. Cognitive function was assessed with a neurocognitive battery. Cognitive impairment was defined as a score 2 SDs below norms for age and education in 2 domains. IADL impairment was defined as needing assistance in at least 1 of 7 IADLs. RESULTS: Among the 126 participants without a prior stroke or TIA, 46 (36.5%) had experienced one or more stroke symptoms. After adjustment for age, sex, race, education, language, diabetes, and cardiovascular disease, participants with stroke symptoms had lower scores on tests of attention, psychomotor speed, and executive function, and more pronounced dependence in IADLs and ADLs (p ≤ 0.01 for all). After adjustment for age, sex, race, education, language, diabetes, and cardiovascular disease, participants with stroke symptoms had a higher likelihood of cognitive impairment (odds ratio [OR] 2.47, 95% confidence interval [CI] 1.03-5.92) and IADL impairment (OR 3.86, 95% CI 1.60-9.28). CONCLUSIONS:Stroke symptoms are common among patients with ESRD and strongly associated with impairments in cognition and functional status. These findings suggest that clinically significant stroke events may go undiagnosed in this high-risk population.
Authors: James A Delmez; Guofen Yan; James Bailey; Gerald J Beck; Srinivasan Beddhu; Alfred K Cheung; George A Kaysen; Andrew S Levey; Mark J Sarnak; Steve J Schwab Journal: Am J Kidney Dis Date: 2006-01 Impact factor: 8.860
Authors: Steven D Weisbord; Linda F Fried; Robert M Arnold; Michael J Fine; David J Levenson; Rolf A Peterson; Galen E Switzer Journal: J Am Soc Nephrol Date: 2005-06-23 Impact factor: 10.121
Authors: Virginia G Wadley; Leslie A McClure; Virginia J Howard; Frederick W Unverzagt; Rodney C Go; Claudia S Moy; Martha R Crowther; Camilo R Gomez; George Howard Journal: Stroke Date: 2007-02-22 Impact factor: 7.914
Authors: A M Murray; D E Tupper; D S Knopman; D T Gilbertson; S L Pederson; S Li; G E Smith; A K Hochhalter; A J Collins; R L Kane Journal: Neurology Date: 2006-07-25 Impact factor: 9.910
Authors: Stephen L Seliger; Daniel L Gillen; David Tirschwell; Haimanot Wasse; Bryan R Kestenbaum; Catherine O Stehman-Breen Journal: J Am Soc Nephrol Date: 2003-10 Impact factor: 10.121
Authors: Mi-Kyung Song; Sandra E Ward; Eric Bair; Lia J Weiner; Jessica C Bridgman; Gerald A Hladik; Constance A Gilet Journal: Hemodial Int Date: 2014-08-08 Impact factor: 1.812
Authors: Manjula Kurella Tamura; Eric Vittinghoff; Chi-Yuan Hsu; Karman Tam; Stephen L Seliger; Stephen Sozio; Michael Fischer; Jing Chen; Eva Lustigova; Louise Strauss; Rajat Deo; Alan S Go; Kristine Yaffe Journal: Kidney Int Date: 2017-01-27 Impact factor: 10.612
Authors: Manjula Kurella Tamura; Glenn M Chertow; Thomas A Depner; Allen R Nissenson; Brigitte Schiller; Ravindra L Mehta; Sai Liu; Tammy L Sirich Journal: J Am Soc Nephrol Date: 2016-07-21 Impact factor: 10.121
Authors: Jesse S Passler; Olivio J Clay; Virginia G Wadley; Fernando Ovalle; Michael Crowe Journal: J Geriatr Psychiatry Neurol Date: 2016-01-21 Impact factor: 2.680
Authors: Gabor Erdoes; Dominik E Uehlinger; Beatrice Kobel; Monika P Stucki; Roland Wiest; Frank Stueber; Niklaus Fankhauser; Stephan M Jakob; Joerg C Schefold Journal: Trials Date: 2018-03-21 Impact factor: 2.279